C
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D/A303.0 KBCTI BIOPHARMA CORPJun 28, 1:51 PM ET·0000921895-23-001590
- 8-K248.6 KBCTI BIOPHARMA CORPJun 26, 8:51 AM ET·0001193125-23-174551
- 8-K180.1 KBCTI BIOPHARMA CORPMay 30, 5:20 PM ET·0001193125-23-156724
- 10-Q3.8 MBCTI BIOPHARMA CORPMay 15, 4:14 PM ET·0000891293-23-000015
- 8-K1.1 MBCTI BIOPHARMA CORPMay 10, 8:05 AM ET·0001193125-23-140076
- SC 13G52.9 KBCTI BIOPHARMA CORPApr 14, 8:25 AM ET·0000935836-23-000361
- SC 13G31.6 KBCTI BIOPHARMA CORPMar 24, 4:49 PM ET·0000935836-23-000345
- 10-K8.7 MBCTI BIOPHARMA CORPMar 6, 4:31 PM ET·0000891293-23-000011
- 8-K312.3 KBCTI BIOPHARMA CORPMar 6, 4:02 PM ET·0000891293-23-000009
- SC 13G/A59.2 KBCTI BIOPHARMA CORPFeb 13, 10:27 AM ET·0000935836-23-000134
Insiders
10- ASELAGE STEVEEVP Global Comm Operations
- BAUER JOHN HDirector
- BAXTER INTERNATIONAL INC10% Owner
- BENNER STEVEN EEVP, Chief Medical Officer
- Bianco James A.Director, CEO
- BIANCO LOUIS AEVP, Finance & Administration
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LP10% Owner, See Explanation of Responses
- BOWMAN JACK LDirector
- Brown JadeEVP, Chief Business Officer
Tickers
No tickers on record
Addresses
business
3101 WESTERN AVENUE SUITE 800
SEATTLE, WA, 98121
mailing
3101 WESTERN AVENUE SUITE 800
SEATTLE, WA, 98121
Former Names
- CELL THERAPEUTICS INC2014-05-29